Vagus nerve stimulation to treat neurodegenerative disorders
US12343535B2 · kind B2 · utility
0Cited by
312References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2020 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Oct 7, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36175
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Systems, devices, and methods for using vagus nerve stimulation to treat demyelination disorders and/or disorder of the blood brain barrier are described. The vagus nerve stimulation therapy described herein is configured to reduce or prevent demyelination and/or promote remyelination to treat various disorders related to demyelination, such as multiple sclerosis. A low duty cycle stimulation protocol with a relatively short on-time and a relatively long off-time can be used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.